Hint mode is switched on Switch off
For swift navigation between sections

CytoMed Therapeutics
LEI 984500AB7AC14B9EE823

PDF download

Choose all Reset all
Download Cancel
Organization name
CytoMed Therapeutics Limited
Country name
Singapore
Country of registration
Singapore
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Cytomed Therapeutics Limited operates as a pre-clinical biopharmaceutical company. The Company focuses on developing novel cell-based immunotherapies for treatment of human cancers. CytoMed Therapeutics serves customers in Singapore.

Awards

News

17/11/2023 CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update
11/05/2023 CytoMed Therapeutics to Ring Nasdaq Closing Bell
18/04/2023 CytoMed Therapeutics Limited Announces Closing of US$9,649,476 Firm Commitment Initial Public Offering
All organization news

Documentation

IFRS/US GAAP reports

2025
IV q eng
2024
IV q eng
2023
IV q eng
2022
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    984500AB7AC14B9EE823
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001873093
  • UEN
    201808327H
Registration is required to get access.